
September 2, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Manuel Ortigão, Marie-Agnes Heine

September 2, 2014 Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates

September 2, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioNTech, Sierk Pötting
September 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GSK, chinese, emerging, market access, pharma, susie lunt

September 1, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, Novartis, als, donald johns

August 29, 2014 Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

August 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mary Beth Loesch, msc

August 28, 2014 Medical Communications, Sales and Marketing Cancer Drugs Fund, Kadclya, Roche, avastin, sovaldi

August 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Xiaohui Zheng, biostar pharmaceuticals

August 28, 2014 Medical Communications, Research and Development, Sales and Marketing Clovis Pharma, Motor Neurone Disease Association

August 27, 2014 Medical Communications, Research and Development, Sales and Marketing Merck, NSCLC, Roche, Xalkori, melanoma, pembrolizumab
August 27, 2014 Medical Communications, Research and Development, Sales and Marketing Africa, Ebola, zmapp

August 26, 2014 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

August 26, 2014 Medical Communications, Sales and Marketing AstraZeneca, CME, CPD, apps, digital

August 26, 2014 Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab